DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Effect of Intranasal Mupirocin on Rate of Staphylococcus Aureus Surgical Site Infection Following Cesarean Sections

Information source: Hillel Yaffe Medical Center
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Surgical Wound Infection; Cesarean Section; Staphylococcus Aureus

Intervention: Mupirocin (Drug)

Phase: N/A

Status: Not yet recruiting

Sponsored by: Hillel Yaffe Medical Center

Summary

The investigators believe that irradication of nose colonization of staphyloccocus aureus will reduce the incidence of surgical site infections after cesarean section.

Clinical Details

Study design: Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention

Primary outcome: Reduction of the incidence of surgical site infections after cesarean section

Eligibility

Minimum age: N/A. Maximum age: N/A. Gender(s): Female.

Criteria:

Inclusion Criteria:

- Women assigned to undergo cesarean section

Exclusion Criteria:

- All others

Locations and Contacts

Hillel Yaffe Medical Center, Hadera 38100, Israel; Not yet recruiting
Gai Shrem, MD, Email: gais@hy.health.gov.il
Gai Shrem, MD, Principal Investigator
Additional Information

Starting date: July 2010
Last updated: June 28, 2010

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017